Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

JAK inhibitors for alopecia areata have different safety risks, requiring specific monitoring for each drug.

Baricitinib 4 mg is effective and safe for treating severe alopecia areata.

Simvastatin/ezetimibe did not effectively treat severe alopecia areata and caused side effects in some patients.

Selumetinib significantly reduced tumor size and improved vision in a child with neurofibromatosis type 1.

Isotretinoin can raise CPK levels, so patients need monitoring, especially before surgery.

Hedgehog pathway inhibitors for advanced basal cell carcinoma can cause side effects, but managing them helps maintain treatment.

Eating pacu-manteiga fish can cause Haff disease, leading to severe muscle damage.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Baricitinib effectively reduces hair loss in severe alopecia areata and is generally safe.

Hair loss may be linked to cardiovascular health problems.

Different sPLA2 enzymes have unique roles in phospholipid metabolism and biological processes.

Combining traditional Chinese medicine with microneedles shows promise for effectively treating skin diseases with fewer side effects.

Upadacitinib is safe and effective for treating alopecia areata and atopic dermatitis in children.

Lotion with fucoidan from brown seaweed improved skin and reduced allergy symptoms in mice with dermatitis.

Oral JAK inhibitors are safe for alopecia areata, but baricitinib may cause more acne and infections.

Ritlecitinib may cause severe musculoskeletal pain in some alopecia universalis patients.

Azelaic acid helps with skin pigmentation issues, but its full effects are not completely understood.

Managing metabolic syndrome needs both lifestyle changes and medical treatments.

Plasmalogens activate a channel in cells that may stimulate hair growth.

De nouvelles thérapies promettent de mieux traiter la perte de cheveux due à l'alopécie androgénétique.

Lifestyle changes can help manage androgenetic alopecia.

Wedelolactone may help treat inflammation, infections, cancer, bone loss, and organ damage.

Janus kinase inhibitors are effective and generally safe for treating hair loss in adults with alopecia areata.

New signs like changes in blood markers, physical symptoms, and behavioral shifts may help detect hidden steroid use in athletes.

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

Eclipta alba has many health benefits and contains compounds with potential for drug development.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Sebaceous glands play a key role in skin health, immunity, and various skin diseases.

Blocking certain receptors in the lungs might help treat a specific type of asthma.